 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              Bombay Stock Exchange has announced that effective from Friday, July 11, 2008; the equity shares of Lotus Eye Care Hospital Limited (Scrip Code: 532998) shall be listed and admitted to dealings on the Exchange in the list of ‘B’ Group of Securities.
The equity shares of Lotus Eye Care Hospital Limited (Symbol: LOTUSEYE) shall be listed and admitted to dealings on the National Stock Exchange w.e.f. July 11, 2008. Trading shall be in the Normal Market segment – Compulsory Demat (Rolling Settlement) for all investors.
The ISIN Code of the company is INE947I01017.
The company issued shares in the recently concluded IPO at a price of Rs. 38/- per share (Face Value of Rs.10/- and premium of Rs. 28/-)
S.K.D.C Consultants Limited is the Registrar to the issue.